Oramed Pharmaceuticals (ORMP) Net Income Attributable to Noncontrolling Interests (2011 - 2025)
Oramed Pharmaceuticals' Income from Non-Controlling Interests came in at -$34,000 for FY2025, compared with -$43,000 in FY2024.
Powered by 
Analysis
Oramed Pharmaceuticals (ORMP) Net Income Attributable to Noncontrolling Interests (2011 - 2025) Analysis & Trends
Going back to FY2022, Oramed Pharmaceuticals' Income from Non-Controlling Interests data covers 4 years.
- The five-year range for annual Income from Non-Controlling Interests is -$1.2 million (FY2022) to $437,000 (FY2023).
- Per Business Quant, earlier years put Income from Non-Controlling Interests at -$43,000 in FY2024, $437,000 in FY2023 and -$1.2 million in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Oramed Pharmaceuticals | 164.02 Mn | -170.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Sep 30, 2024 | -23,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 834,000.00 |
| Sep 30, 2023 | -62,000.00 |
| Jun 30, 2023 | -119,000.00 |
| Mar 31, 2023 | -216,000.00 |
| Dec 31, 2022 | -193,000.00 |
| Sep 30, 2022 | -193,000.00 |
| Jun 30, 2022 | -534,000.00 |
| Mar 31, 2022 | -283,000.00 |
| Nov 30, 2021 | 208,000.00 |
| May 31, 2021 | 418,000.00 |
| Nov 30, 2017 | 326,000.00 |
| Feb 28, 2014 | -512,812.00 |
| Nov 30, 2013 | -334,173.00 |
| Feb 28, 2013 | -8.64 Mn |
API Access
Oramed Pharmaceuticals Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ORMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "ORMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ORMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();